USADA announced today that Jorge Gonzalez Villa, of Mexico City, Mexico, has accepted a two-year sanction for a violation of the UFC^® Anti-Doping Policy. Gonzalez Villa, 36, tested positive for stanozolol metabolites 16β-hydroxystanozolol and 4β-hydroxystanozolol, drostanolone metabolite 2α-methyl-5α-androstan-3α-ol-17-one, and tamoxifen metabolite 3-hydroxy-4-methoxytamoxifen as the result of a urine sample collected out-of-competition on August 5, 2020. Stanozolol and drostanolone are non-Specified Substances in the class of Anabolic Agents, while tamoxifen is a Specified Substance in the class of Hormone and Metabolic Modulators. These substances are prohibited at all times under the UFC Anti-Doping Policy and UFC Prohibited List.

Upon being added to the UFC Anti-Doping Program, athletes are required to declare all medications and supplements they have used in the previous 12 months. An athlete who declares the prior use of a prohibited substance will not be deemed to have committed a violation but, depending on the substance, may be required to refrain from competition for a period of at least six months and provide at least two negative samples. Gonzalez Villa did not declare the use of stanozolol, drostanolone, or tamoxifen on his onboarding declaration forms.

As a result of his positive test, Gonzalez Villa was removed from a scheduled bout on August 22, 2020. Gonzalez Villa’s two-year period of ineligibility began on August 5, 2020, the date his positive sample was collected.

• This media release was published by the Ultimate Fighting Championships (UFC) and the US Anti-Doping Agency (USADA) on 11 September 2020. Click here for the original.